Osteoarthritis Market is expected to showcase exceptional Growth by 2032 – Estimates DelveInsight | Key Companies- Novartis, Peptinov, 4P Pharma, Sorrento, Eupraxia, Biosplice, Ampio, Bone Therapeutics, & Others

Osteoarthritis, also known as the degenerative joint disease (DJD) is the most common form of arthritis. It occurs when the protective cartilage which cushions the ends of the bones wears over a period of time. The disease is likely to progress as people age. Inflammation and injury caused to the joint might lead to bony changes, deterioration of Tendons and ligaments and a breakdown of cartilage, resulting in pain, swelling, and deformity of the joint.

DelveInsight's "Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Osteoarthritis, historical and forecasted epidemiology as well as the Osteoarthritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

Some facts of Osteoarthritis Market Report:

· According to the EULAR Study Group (2015), it was estimated that OA affects about 40 million people in Europe. It was relatively infrequent in people under the age of 40 years but increased definitely with age. Under the age of 45 women were less affected than males which reverse above the age of 45.

· Osteoarthritis (OA) is the 4th leading cause of disability across the world and is thought to be the most prevalent of all musculoskeletal pathologies, affecting an estimated 10% of the world’s population over the age of 60.

· According to Osteoarthritis Action Alliance, while there are estimated to be more than 100 types of arthritis, OA is the most common form of arthritis, affecting 32.5 million US adults. 43% of people with OA are 65 or older and 88% of people with OA are 45 or older. 62% of individuals with OA are women. Among people younger than 45, OA is more common among men; above age 45, OA is more common among women.

· Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment can act as a market barrier.

Get More Detailed Insights into the Osteoarthritis Market Report: https://www.delveinsight.com/sample-request/osteoarthritis-market

Symptoms associated with osteoarthritis

Osteoarthritis symptoms tend to develop slowly and worsen gradually with time. The signs and symptoms of osteoarthritis include, pain as the affected joints might hurt as a result of movement, joint stiffness, tenderness, when the individual applies light pressure to or near it, loss of flexibility, grating sensation when the individual hears popping or crackling, bone spurs or extra bits of bone that feels like a hard lump and forms around the affected joint, swelling that might result due to soft tissue inflammation around the joint.

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

Osteoarthritis Diagnosis

Osteoarthritis is primarily a clinical diagnosis. However, plain radiography can be helpful in confirming the diagnosis and ruling out other pathology.34 MRI and computed tomography are rarely needed. There are certain plain radiographic findings characteristic of Osteoarthritis. Osteoarthritis often demonstrates joint space narrowing, osteophyte formation, subchondral sclerosis, and cysts.

Key Benefits of Osteoarthritis Market Report

The report provides an in-depth analysis of Osteoarthritis Market Size and Share till 2032 in the 7MM.
The report will help in developing business strategies by understanding the Osteoarthritis Market Trends, key players, and ongoing developments activities, that shape and drive the market growth in the upcoming years.
It covers Osteoarthritis’s current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.
The report provides a detailed assessment of the Osteoarthritis market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors.

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

Osteoarthritis Pipeline therapies and Companies:

· DK 004: Jiangsu Carephar Pharmaceutical

· 4P-004: 4P Pharma

· LNA043: Novartis

· LRX712: Novartis

· X 0002: Techfields Pharma

· DMI 9523: Ampio Pharmaceuticals

· PPV-06: Peptinov

· And Others.

Get More Detailed Insights into the Emerging Therapies & Key Companies: https://www.delveinsight.com/sample-request/osteoarthritis-market

The Osteoarthritis therapeutics market has a promising outlook with the emerging therapies, consisting of several Phase III and Phase II assets.

Osteoarthritis Market Drivers

· Growing geriatric population and hence the rising prevalence of osteoarthritis

· Favorable government policies to support the development of new therapies for the Osteoarthritis, and Others

Table of Content

1. Key Insights

2. Executive Summary

3. Osteoarthritis Competitive Intelligence Analysis

4. Osteoarthritis Market Overview at a Glance

5. Osteoarthritis Disease Background and Overview

6. Osteoarthritis Patient Journey

7. Osteoarthritis Epidemiology and Patient Population

8. Osteoarthritis Treatment Algorithm, Current Treatment, and Medical Practices

9. Osteoarthritis Unmet Needs

10. Key Endpoints of Osteoarthritis Treatment

11. Osteoarthritis Marketed Products

12. Osteoarthritis Emerging Therapies

13. Osteoarthritis Seven Major Market Analysis

14. Attribute Analysis

15. Osteoarthritis Market Outlook (7 major markets)

16. Osteoarthritis Access and Reimbursement Overview

17. KOL Views on the Osteoarthritis Market.

18. Osteoarthritis Market Drivers

19. Osteoarthritis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

View Report: https://www.delveinsight.com/report-store/osteoarthritis-market

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

· Bacteremia Market

· Central Retinal Vein Occlusion Market

· Chondrosarcoma Market

· Microsatellite Stable Colorectal Cancer Market

· Progressive Multifocal Leukoencephalopathy Market

· Prosthetic Joint Infection Market

· Higher-Risk Chronic Myelomonocytic Leukemia Market

· Upper Limb Hypertonia Market

· X-linked Retinitis Pigmentosa Market

· Metachromatic Leukodystrophy Market

· Idiopathic Membranous Nephropathy Market

· Nevoid Basal Cell Carcinoma Syndrome Market